Skip to main content

Table 1 Characteristics of patients with SBCa following RNU for non-metastatic UTUC

From: Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value

Variables

Number of cases

Age in years, n (%)

 < 60

36 (18.0)

 60–79

115 (57.5)

 ≥ 80

49 (24.5)

Gender, n (%)

 Male

113 (56.5)

 Female

87 (43.5)

Race, n (%)

 White

182 (91.0)

 Black

6 (3.0)

 Other

12 (6.0)

UTUC laterality, n (%)

 Left

103 (51.5)

 Right

97 (47.5)

UTUC location, n (%)

 Pelvis

132 (66.0)

 Ureter

68 (34.0)

UTUC stage, n (%)

 pTa-1

90 (45.0)

 pT2-3

110 (55.0)

Histopathological UTUC, n (%)

 Low (well and moderately differentiated)

49 (24.5)

 High (poorly differentiated and undifferentiated)

151 (75.5)

SBCa location, n (%)

 Non-surgical Site (bladder dome, neck or later wall)

42 (21.0)

 Surgical site (bladder trigone, anterior or posterior wall)

53 (26.5)

 Multiple site (multifocal tumors)

105 (52.5)

SBCa stage, n (%)

 pTa-1

180 (90.0)

 pT2-4

20 (10.0)

Histopathological SBCa grade, n (%)

 Low (well and moderately differentiated)

82 (41.0)

 High (poorly differentiated and undifferentiated)

118 (59.0)

Recurrence time in months, n (%)

 Time ≤ 6

53 (26.5)

 6 < Time ≤ 24

74 (37.0)

 Time > 24

73 (36.5)

Follow–up in months, median (IQR)

71 (36.0, 103.8)

  1. RNU Radical nephroureterectomy, SBCa Secondary bladder cancer, pT Pathological tumour, UTUC Upper tract urothelial carcinoma